{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:37:29Z","timestamp":1792517849705,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science and Technology Council, Taiwan","award":["110-2320-B-038-072-MY2 and 113-2314-B-038-034-MY3"],"award-info":[{"award-number":["110-2320-B-038-072-MY2 and 113-2314-B-038-034-MY3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25534-y","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:43:54Z","timestamp":1763988234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tumor-derived lactate fuels the STAT3-LCN2 pathway to promote bladder cancer malignancy and chemoresistance"],"prefix":"10.1038","volume":"15","author":[{"given":"Shih-Yu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hao","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chen","family":"Hsiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Xin","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuen-Haur","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"3","key":"25534_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"25534_CR2","first-page":"15","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala, K. et al. Epidemiology of bladder cancer. Med. Sci. 8 (1), 15 (2020).","journal-title":"Med. Sci."},{"key":"25534_CR3","doi-asserted-by":"crossref","unstructured":"Abugomaa, A. et al. Emerging roles of cancer stem cells in bladder cancer Progression, Tumorigenesis, and resistance to chemotherapy: A potential therapeutic target for bladder cancer. Cells, 9(1). (2020).","DOI":"10.3390\/cells9010235"},{"issue":"5","key":"25534_CR4","doi-asserted-by":"publisher","first-page":"e0269214","DOI":"10.1371\/journal.pone.0269214","volume":"18","author":"A Hamid","year":"2023","unstructured":"Hamid, A. et al. The expression of stem cells markers and its effects on the propensity for recurrence and metastasis in bladder cancer: A systematic review. PLoS One. 18 (5), e0269214 (2023).","journal-title":"PLoS One"},{"issue":"3","key":"25534_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 41 (3), 374\u2013403 (2023).","journal-title":"Cancer Cell."},{"issue":"1","key":"25534_CR6","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/s41467-019-09878-4","volume":"10","author":"YC Lee","year":"2019","unstructured":"Lee, Y. C. et al. Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung. Nat. Commun. 10 (1), 2131 (2019).","journal-title":"Nat. Commun."},{"issue":"5","key":"25534_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/15384101.2022.2154551","volume":"22","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer. Cell. Cycle. 22 (5), 610\u2013618 (2023).","journal-title":"Cell. Cycle"},{"issue":"9","key":"25534_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41585-022-00608-y","volume":"19","author":"YC Lee","year":"2022","unstructured":"Lee, Y. C. et al. The dynamic roles of the bladder tumour microenvironment. Nat. Rev. Urol. 19 (9), 515\u2013533 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"25534_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","volume":"45","author":"F Massari","year":"2016","unstructured":"Massari, F. et al. Metabolic phenotype of bladder cancer. Cancer Treat. Rev. 45, 46\u201357 (2016).","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"25534_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg, O., Wind, F., Negelein, E. & THE METABOLISM OF TUMORS IN THE BODY. J. Gen. Physiol., 8(6): 519\u2013530. (1927).","journal-title":"J. Gen. Physiol."},{"issue":"1","key":"25534_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yexcr.2015.04.007","volume":"335","author":"VR Conde","year":"2015","unstructured":"Conde, V. R. et al. The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism. Exp. Cell. Res. 335 (1), 91\u201398 (2015).","journal-title":"Exp. Cell. Res."},{"issue":"5","key":"25534_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu, P. P. & Sabatini, D. M. Cancer cell metabolism: Warburg and beyond. Cell 134 (5), 703\u2013707 (2008).","journal-title":"Cell"},{"key":"25534_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","volume":"87","author":"D Sharma","year":"2022","unstructured":"Sharma, D., Singh, M. & Rani, R. Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics. Sem. Cancer Biol. 87, 184\u2013195 (2022).","journal-title":"Sem. Cancer Biol."},{"issue":"2","key":"25534_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0360-3016(01)01630-3","volume":"51","author":"DM Brizel","year":"2001","unstructured":"Brizel, D. M. et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 51 (2), 349\u2013353 (2001).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"25534_CR15","first-page":"916","volume":"60","author":"S Walenta","year":"2000","unstructured":"Walenta, S. et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 60 (4), 916\u2013921 (2000).","journal-title":"Cancer Res."},{"key":"25534_CR16","doi-asserted-by":"publisher","first-page":"216837","DOI":"10.1016\/j.canlet.2024.216837","volume":"590","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. The emerging role of lactate in tumor microenvironment and its clinical relevance. Cancer Lett. 590, 216837 (2024).","journal-title":"Cancer Lett."},{"key":"25534_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","volume":"9","author":"KG de la Cruz-L\u00f3pez","year":"2019","unstructured":"de la Cruz-L\u00f3pez, K. G. et al. Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front. Oncol. 9, 1143 (2019).","journal-title":"Front. Oncol."},{"issue":"1","key":"25534_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0006-291X(05)81256-2","volume":"180","author":"DR Flower","year":"1991","unstructured":"Flower, D. R., North, A. C. T. & Attwood, T. K. Mouse oncogene protein 24p3 is a member of the Lipocalin protein family. Biochem. Biophys. Res. Commun. 180 (1), 69\u201374 (1991).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"25534_CR19","doi-asserted-by":"publisher","first-page":"1195501","DOI":"10.3389\/fmed.2023.1195501","volume":"10","author":"A Galaris","year":"2023","unstructured":"Galaris, A. et al. Increased lipocalin-2 expression in pulmonary inflammation and fibrosis. Front. Med. (Lausanne). 10, 1195501 (2023).","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"25534_CR20","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1038\/s41598-020-72172-7","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Hepatic Lipocalin 2 promotes liver fibrosis and portal hypertension. Sci. Rep. 10 (1), 15558 (2020).","journal-title":"Sci. Rep."},{"issue":"10","key":"25534_CR21","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2337\/db07-0007","volume":"56","author":"QW Yan","year":"2007","unstructured":"Yan, Q. W. et al. The adipokine Lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56 (10), 2533\u20132540 (2007).","journal-title":"Diabetes"},{"issue":"11","key":"25534_CR22","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1172\/JCI42004","volume":"120","author":"A Viau","year":"2010","unstructured":"Viau, A. et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J. Clin. Invest. 120 (11), 4065\u20134076 (2010).","journal-title":"J. Clin. Invest."},{"issue":"6","key":"25534_CR23","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.18632\/oncotarget.1738","volume":"5","author":"S Candido","year":"2014","unstructured":"Candido, S. et al. Roles of neutrophil gelatinase-associated Lipocalin (NGAL) in human cancer. Oncotarget 5 (6), 1576\u20131594 (2014).","journal-title":"Oncotarget"},{"issue":"10","key":"25534_CR24","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/ijc.21657","volume":"118","author":"HJ Lee","year":"2006","unstructured":"Lee, H. J. et al. Ectopic expression of neutrophil gelatinase-associated Lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int. J. Cancer. 118 (10), 2490\u20132497 (2006).","journal-title":"Int. J. Cancer"},{"issue":"15","key":"25534_CR25","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1158\/0008-5472.CAN-08-0540","volume":"68","author":"Z Tong","year":"2008","unstructured":"Tong, Z. et al. Neutrophil gelatinase\u2013associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 68 (15), 6100\u20136108 (2008).","journal-title":"Cancer Res."},{"issue":"7","key":"25534_CR26","doi-asserted-by":"publisher","first-page":"9855","DOI":"10.1007\/s13277-016-4872-x","volume":"37","author":"S Candido","year":"2016","unstructured":"Candido, S. et al. Diagnostic value of neutrophil gelatinase-associated lipocalin\/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder. Tumour Biol. 37 (7), 9855\u20139863 (2016).","journal-title":"Tumour Biol."},{"issue":"W1","key":"25534_CR27","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45 (W1), W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"25534_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul, P. J. & Lindskog, C. The human protein atlas: A Spatial map of the human proteome. Protein Sci. 27 (1), 233\u2013244 (2018).","journal-title":"Protein Sci."},{"issue":"1","key":"25534_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2014.11.046","volume":"358","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z. et al. Oxamate-mediated Inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the Akt\u2013mTOR signaling pathway. Cancer Lett. 358 (1), 17\u201326 (2015).","journal-title":"Cancer Lett."},{"issue":"15_suppl","key":"25534_CR30","doi-asserted-by":"publisher","first-page":"9093","DOI":"10.1200\/JCO.2016.34.15_suppl.9093","volume":"34","author":"C Becerra","year":"2016","unstructured":"Becerra, C. et al. A phase Ib\/II study of cancer stemness inhibitor Napabucasin (BB608) combined with weekly Paclitaxel in advanced non-small cell lung cancer. J. Clin. Oncol. 34 (15_suppl), 9093\u20139093 (2016).","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"25534_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41585-019-0226-y","volume":"16","author":"AK Schneider","year":"2019","unstructured":"Schneider, A. K., Chevalier, M. F. & Derr\u00e9, L. The multifaceted immune regulation of bladder cancer. Nat. Reviews Urol. 16 (10), 613\u2013630 (2019).","journal-title":"Nat. Reviews Urol."},{"issue":"1","key":"25534_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00262-019-02443-4","volume":"69","author":"PL Crispen","year":"2020","unstructured":"Crispen, P. L. & Kusmartsev, S. Mechanisms of immune evasion in bladder cancer. Cancer Immunol. Immunother. 69 (1), 3\u201314 (2020).","journal-title":"Cancer Immunol. Immunother"},{"key":"25534_CR33","doi-asserted-by":"crossref","unstructured":"\u017divalj, M., Van Ginderachter, J. A. & Stijlemans, B. Lipocalin-2: A nurturer of tumor progression and a novel candidate for targeted cancer therapy. Cancers (Basel), 15(21). (2023).","DOI":"10.3390\/cancers15215159"},{"issue":"8","key":"25534_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/1354750X.2015.1123354","volume":"20","author":"V Abella","year":"2015","unstructured":"Abella, V. et al. The potential of lipocalin-2\/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers 20 (8), 565\u2013571 (2015).","journal-title":"Biomarkers"},{"key":"25534_CR35","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2147\/JAA.S418596","volume":"16","author":"L Xu","year":"2023","unstructured":"Xu, L. & Shi, M. Lipocalin 2 (LCN2) knockdown regulates Treg\/Th17 balance to improve asthma in mice. J. Asthma Allergy. 16, 1323\u20131332 (2023).","journal-title":"J. Asthma Allergy"},{"issue":"11","key":"25534_CR36","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/jgh.12597","volume":"29","author":"RM Janas","year":"2014","unstructured":"Janas, R. M. et al. Neutrophil gelatinase-associated Lipocalin in blood in children with inflammatory bowel disease. J. Gastroenterol. Hepatol. 29 (11), 1883\u20131889 (2014).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"25534_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fimmu.2020.00299","volume":"11","author":"T Huang","year":"2020","unstructured":"Huang, T. et al. Stroke exacerbates cancer progression by upregulating LCN2 in PMN-MDSC. Front. Immunol. 11, 299 (2020).","journal-title":"Front. Immunol."},{"issue":"7","key":"25534_CR38","doi-asserted-by":"publisher","first-page":"e101881","DOI":"10.1371\/journal.pone.0101881","volume":"9","author":"M Floderer","year":"2014","unstructured":"Floderer, M., Prchal-Murphy, M. & Vizzardelli, C. Dendritic cell-secreted lipocalin2 induces CD8\u2009+\u2009T-cell apoptosis, contributes to T-cell priming and leads to a TH1 phenotype. PLoS One. 9 (7), e101881 (2014).","journal-title":"PLoS One"},{"key":"25534_CR39","doi-asserted-by":"publisher","first-page":"808859","DOI":"10.3389\/fcell.2022.808859","volume":"10","author":"M Jin","year":"2022","unstructured":"Jin, M. et al. Tumor-Derived lactate creates a favorable niche for tumor via supplying energy source for tumor and modulating the tumor microenvironment. Front. Cell. Dev. Biol. 10, 808859 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"12","key":"25534_CR40","doi-asserted-by":"publisher","first-page":"110986","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu, J. et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells. Cell. Rep. 39 (12), 110986 (2022).","journal-title":"Cell. Rep."},{"issue":"1","key":"25534_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu, X. et al. The JAK\/STAT signaling pathway: from bench to clinic. Signal. Transduct. Target. Therapy. 6 (1), 402 (2021).","journal-title":"Signal. Transduct. Target. Therapy"},{"issue":"1","key":"25534_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s11658-018-0078-0","volume":"23","author":"M Galoczova","year":"2018","unstructured":"Galoczova, M., Coates, P. & Vojtesek, B. STAT3, stem cells, cancer stem cells and p63. Cell. Mol. Biol. Lett. 23 (1), 12 (2018).","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"25534_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","volume":"43","author":"Y Hu","year":"2024","unstructured":"Hu, Y., Dong, Z. & Liu, K. Unraveling the complexity of STAT3 in cancer: molecular Understanding and drug discovery. J. Exp. Clin. Cancer Res. 43 (1), 23 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"25534_CR44","doi-asserted-by":"publisher","first-page":"e0312424","DOI":"10.1371\/journal.pone.0312424","volume":"20","author":"F Maleki","year":"2025","unstructured":"Maleki, F., Handali, S. & Rezaei, M. The role of mitochondrial dysfunction in the cytotoxic synergistic effect of gemcitabine and arsenic on breast cancer. PLoS One. 20 (1), e0312424 (2025).","journal-title":"PLoS One"},{"issue":"9","key":"25534_CR45","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1002\/jps.20874","volume":"96","author":"T Ozben","year":"2007","unstructured":"Ozben, T. Oxidative stress and apoptosis: impact on cancer therapy. J. Pharm. Sci. 96 (9), 2181\u20132196 (2007).","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"25534_CR46","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1158\/1535-7163.MCT-14-0420","volume":"14","author":"HQ Ju","year":"2015","unstructured":"Ju, H. Q. et al. Mechanisms of overcoming intrinsic resistance to gemcitabine in pancreatic ductal adenocarcinoma through the redox modulation. Mol. Cancer Ther. 14 (3), 788\u2013798 (2015).","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"25534_CR47","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12935-024-03558-0","volume":"24","author":"BA Mengistu","year":"2024","unstructured":"Mengistu, B. A. et al. Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy. Cancer Cell. Int. 24 (1), 406 (2024).","journal-title":"Cancer Cell. Int."},{"issue":"3","key":"25534_CR48","first-page":"457","volume":"2","author":"T Murayama","year":"2019","unstructured":"Murayama, T. & Gotoh, N. Drug resistance mechanisms of cancer stem-like cells and their therapeutic potential as drug targets. Cancer Drug Resist. 2 (3), 457\u2013470 (2019).","journal-title":"Cancer Drug Resist."},{"issue":"7","key":"25534_CR49","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/MIB.0000000000001134","volume":"23","author":"P Saha","year":"2017","unstructured":"Saha, P. et al. Ectopic expression of innate immune Protein, Lipocalin-2, in Lactococcus lactis protects against gut and environmental stressors. Inflamm. Bowel Dis. 23 (7), 1120\u20131132 (2017).","journal-title":"Inflamm. Bowel Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25534-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25534-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25534-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T01:02:17Z","timestamp":1764378137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25534-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25534"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25534-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41610"}}